edited by Edward D. Levin
Animal Models of Cognitive Impairment provides integrated coverage of the latest research concerning neuronal systems relevant to cognitive function and dysfunction.
Features:
- Integrates molecular and neurochemical approaches to behavioral application in translational animal models and clinical applications
- Features cutting-edge research on genetic, lesion, pharmacological toxicant, and aging models
- Includes contributions from distinguished active researchers in the field of cognitive therapy research
Contents
Pharmacologic Models
- Muscarinic Receptor Antagonists in Rats
- Nicotinic Receptor Antagonists in Rats
- Involvement of the NMDA System in Learning and Memory
- Animal Models and the Cognitive Effects of Ethanol
Toxicologic Models
- Animal Models of Cognitive Impairment Produced
by Developmental Lead Exposure
- Developmental Behavioral Toxicity of Methylmercury:
Consequences, Conditioning, and Cortex
- Executive Function Following Developmental Exposure to
Polychlorinated Biphenyls (PCBs): What Animal Models
Have Told Us
- Modeling Cognitive Deficits Associated with Parkinsonism
in the Chronic-Low-Dose MPTP-Treated Monkey
Mouse Genetic Models
- Cognitive Impairment in Transgenic Mouse Models
of Amyloid Deposition
- Cholinergic Receptor Knockout Mice
- Assessments of Cognitive Deficits in Mutant Mice
Model Applications and Future Developments
- Cognitive Pharmacology in Aging Macaques
- Cognitive Impairment following Traumatic Brain Injury
- Cognitive Impairment Models Using Complementary Species
- Cognition Models and Drug Discovery
Index